Doctors avoid cut in Medicare pay, but not for drugs

Article Overview

This article is for healthcare billing and coding professionals who need to understand a Medicare payment update that affects physician services and a separate change affecting payment for physician-administered drugs and injectables. It summarizes the role of the federal drug pricing program, the general shift in reimbursement methodology, and the impact on drug pricing in office-based and other covered settings. The piece is relevant to practices that bill Medicare Part B and to readers tracking reimbursement changes tied to CMS pricing policy.